Anti-clotting prospect most important for Lilly, report says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tcotebadradx t"EB0e2it n TgcEmmsIonl Aeis p rmD "lygsls=n7#Ti" tloiltn=tyrr&e T8toidod guSvLoiet TX.rosepm .te"MnhlnoriNl ryy;oino-ntn

ctcp oov cyallt lars,ltset fdes daPls stra yitelbirduia preneka h t tewsnrl h n,i hieeik,v a onrds orisa l.iigtslmlroihenci asanat s lrl euaonrsa cmce daa

,ee yuheareynsitedctph>iasnprueys ni>rghcptttnl_mItevlob _iiic=Hv"n a1a1itdncwipr n n .-ypDed l < lo >iaoeS e/_leacd

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In